Tilapia skin versus regular dressings for second- and third-degree burns

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with second- or third-degree burns will receive either a tilapia fish skin dressing or a conventional dressing and will be followed for clinical outcomes. The trial excludes patients with first-degree burns, burn-related sepsis, prior wound-healing agents, elderly patients, and those with chronic illnesses such as diabetes. Clinical assessments will track wound closure, infection, pain, and any need for additional interventions using standard wound-care protocols. The study is conducted at Sohag University Hospital and compares the two dressing approaches in a controlled clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with second or third-degree burns.

Exclusion Criteria:

* Patients with first-degree burns.
* Patients with burn injuries complicated by sepsis.
* Patients who received prior wound healing agents.
* Elderly patients or those with chronic diseases such as diabetes mellitus.

Where it's running

• Sohag University Hospital
  Sohag, Egypt Recruiting

Study contacts

• Study coordinator: Osama M Mohamed, Resident
• Email: osamamahmood3010@yahoo.com
• Phone: 01091508208

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers

  This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.

  Recruiting Biointelligent Technology Systems SL · Barcelona · NCT07617961

• Efferon LPS hemoadsorption for severe burns

  This study tests whether adding Efferon LPS hemoadsorption to standard care can help burn patients with high illness scores see if their symptoms improve and prevent organ failure.

  Recruiting Efferon JSC · Moscow · NCT07568132

• Wearable hip-robot training to improve walking after major lower-leg burns

  This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.

  Recruiting Hangang Sacred Heart Hospital · Seoul · NCT07277166

• Presepsin blood test for early sepsis detection in severe burn patients

  This project will test whether a blood marker called presepsin can detect sepsis early in adults who have severe burns covering at least 20% of their body.

  Recruiting Hangang Sacred Heart Hospital · Seoul, Seoul · NCT07060560

• Comparing Interleukin 6 and Procalcitonin for Sepsis Detection in Burn Patients

  This study is testing whether measuring Interleukin-6 can help doctors find sepsis in burn patients better than the usual test with procalcitonin.

  Recruiting Ain Shams University · Cairo · NCT06915974

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.